NRPRNutri Pharmaceuticals Research, Inc.

About Nutri Pharmaceuticals Research, Inc. (NRPR)

Nutri Pharmaceuticals Research, Inc. (NRPR) is a Drug Manufacturers - Specialty & Generic company headquartered in Las Vegas, NV, United States whose shares trade over-the-counter on the Pink tier.

Manufacturer of Specialty Products. (CBD) and Amazon reseller

Products and services

Until the divestment of the assets of our operating subsidiary in June, 2021 we were engaged in the business of our process that transforms most edible oils into a free-flowing powder form that we term “Oil to Powder” or O2P™. As of June 30, 2021, our business consists of a marketing business under which we market and distribute products on amazon.com, and in our development of CBD products for consumers.

NRPR key facts

Ticker symbol

NRPR

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Las Vegas, NV, United States

Country of incorporation

US

Year of incorporation

2001

Employees

1

Estimated market cap

$347.5K (as of May 13, 2025)

Shares outstanding

16,546,766

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Nutri Pharmaceuticals Research, Inc. leadership

• Godfrey Yew — President, CEO, Secretary
• Zachary Takos — Counsel

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with N